Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).

NCT02556229 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Choroidal Neovascularization

Interventions

DRUG: Aflibercept

Sponsor

Hospices Civils de Lyon